article thumbnail

The Language of Serious Illness: A Podcast with Sunita Puri, Bob Arnold, and Jacqueline Kruser

GeriPal

I felt like I was always told to present people with a buffet of options and, really, without guidance, ask them to choose, which is, it would always make me feel sick to my stomach. But I think what I didn’t know was that when somebody makes a decision to get to a certain event that the work isn’t done then.

article thumbnail

Surgical Communication: A Podcast with Gretchen Schwarze, Justin Clapp and Alexis Colley

GeriPal

I love this series of articles because each presents a component of a practical, patient-centered approach to patient-surgeon communication and decision making, and language surgeons (and surgical trainees) can start using in their next patient visit. Gretchen: Absolutely. And I think it came out of this good space. Gretchen: Yeah.

Article 245
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Analysis of U.S. Food and Drug Administration Draft Guidance on Clinical Trials with Psychedelic Drugs

Healthcare Law Insights blog

Clinical safety reporting should track all abuse-related adverse events (AEs), such as euphoria, hallucinations, stimulation, and emotional lability. Clinical FDA believes that the characteristics of psychedelic drugs present challenges in designing adequate and well-controlled (AWC) clinical studies.

article thumbnail

Undisclosed Conflicts of Interest by Physicians Creating the CDC Opioid Prescribing Guidelines: Bad Faith or Incompetence?

Pallimed

WLF’s complaint compelled the CDC to re-open a second open comment period for the public, lasting 30 days in duration, rather than the two-day period for comment which CDC had originally presented via a September 2015 webinar (4, 35). Presented on February 10, 2022, for the Annual Assembly of Hospice and Palliative Care (Virtual Conference).

2016 145
article thumbnail

Jumpstarting Goals of Care Convos: Erin Kross, Bob Lee, and Ruth Engelberg

GeriPal

And so Ruth highlighted one of the features of this pragmatic trial that was different than the outpatient trial was that we didn’t need to consent patients and families for participation in this study. And so that’s how we were able to proceed with the study under this waiver of consent. Erin: Code status.

Document 158